Example: Heart Attack

Search clinical trials for: Cefepime

Total 70 results

NCT03680612

Completed

Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI

Conditions: Urinary Tract Infections
NCT02568800

Unknown status

Prolonged Infusion Cefepime and Nosocomial Infections

Conditions: Urinary Tract Infection; Respiratory Tract Infection
NCT02302092

Terminated

An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections

Conditions: Urinary Tract Infection
NCT04009772

Recruiting

Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section

Conditions: Emergency Cesarean Section; Infection Wound
NCT00609375

Completed

Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen

Conditions: Sepsis; Bacteremia
NCT03680352

Unknown status

Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects

Conditions: PK in Patients With Various Degrees of Renal Impairment
NCT01484015

Completed

Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia

Conditions: Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Adult Burkitt Lymphoma; Adult Diffuse Large Cell Lymphoma; Adult Diffuse Mixed Cell Lymphoma; Adult Diffuse Small Cleaved Cell Lymphoma; Adult Hodgkin Lymphoma; Adult Immunoblastic Large Cell Lymphoma; Adult Lymphoblastic Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Breast Cancer; Chronic Eosinophilic Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Cutaneous T-cell Non-Hodgkin Lymphoma; Disseminated Neuroblastoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3 Follicular Lymphoma; Malignant Testicular Germ Cell Tumor; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Multiple Myeloma; Mycosis Fungoides/Sezary Syndrome; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neutropenia; Nodal Marginal Zone B-cell Lymphoma; Ovarian Epithelial Cancer; Ovarian Germ Cell Tumor; Plasma Cell Neoplasm; Poor Prognosis Metastatic Gestational Trophoblastic Tumor; Primary Myelofibrosis; Prolymphocytic Leukemia; Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma
NCT03680378

Completed

Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)

Conditions: Healthy Subjects
NCT03840148

Recruiting

Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections

Conditions: Urinary Tract Infections; Acute Pyelonephritis
NCT01852630

Completed

Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure

Conditions: Spontaneous Bacterial Peritonitis
NCT02497781

Completed

Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)

Conditions: Complicated Urinary Tract Infections
NCT02680600

Completed

Individualized Cefepime Dosing Study

Conditions: Antimicrobial Treatment
NCT03687255

Completed

Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections

Conditions: Urinary Tract Infections
NCT04187755

Completed

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

Conditions: Neutropenia, Febrile; Leukemia; Pediatric Cancer; Antibiotic Reaction
NCT02872038

Completed

Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis

Conditions: Peritoneal Dialysis Associated Peritonitis
NCT00358202

Completed

Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia

Conditions: Pneumonia
NCT02532140

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime

Conditions: Healthy
NCT00497744

Completed

A Pharmacokinetic Study of Cefepime After Administration Into Dialysate in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis

Conditions: Peritonitis
NCT02820987

Unknown status

PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock

Conditions: Septic Shock
NCT01110408

Terminated

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections

Conditions: Complicated Urinary Tract Infections or Pyelonephritis
NCT01110421

Terminated

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia

Conditions: Pneumonia, Bacterial; Community-Acquired Infections; Nosocomial Infection; Pneumonia, Ventilator-Associated
NCT00137787

Completed

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

Conditions: Febrile Neutropenia
NCT00020865

Unknown status

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Conditions: Fever, Sweats, and Hot Flashes; Infection; Leukemia; Lymphoma; Neutropenia; Unspecified Adult Solid Tumor, Protocol Specific
NCT03870490

Completed

Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects

Conditions: Healthy Subjects
NCT02688582

Completed

Target-controlled Infusion Model for Cefepime

Conditions: Antimicrobial Treatment